OrganTech completes fundraising for its next growth stage
Summary
OrganTech announced that it has completed a new funding round to accelerate its next growth stage. The company will use the capital to advance research and clinical development for Bio-hybrid Tooth and its third-cell hair regeneration work. It also plans to strengthen regulatory readiness, manufacturing scale-up, and global partnerships, especially for U.S. expansion and FDA preparation. The release highlights ongoing licensing and clinical collaborations that support commercialization of its regenerative medicine pipeline.
Funding
Amount
None
Total raised
Date
June 3, 2026
Announcement date
Investors
-
Lead investors
Company
organ-tech.jp
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected